Select for export Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-25 University of Texas at Austin ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionBrain ImagingBiomarkers Clinical Trial More
Select for export A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-025-29642-7 PubMed 41290975 Copy citation Copy BibTeX Scientific Reports 2025-11-25 Małgorzata Domżalska, Joanna Kwiatkowska, Iwona Cichoń, Ewa Sokołowska OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Psilocybin reduces comorbid chronic pain and depression in mice No abstract availability was recorded for this entry. Details DOI 10.1038/s41684-025-01663-9 PubMed 41298885 Copy citation Copy BibTeX Lab Animal 2025-11-25 Jorge Ferreira OpenAlex Published psilocybin DepressionChronic PainPharmacology Animal Study More
Select for export Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-24 Charles S. Grob, M.D. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/28314425251394012 Copy citation Copy BibTeX Psychedelic Medicine 2025-11-23 J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell OpenAlex Published psilocybin DepressionAnxietyOCD Systematic Review More
Select for export Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/ms9.0000000000004349 PubMed 41497122 Copy citation Copy BibTeX Annals of Medicine and Surgery 2025-11-23 Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Other More
Select for export Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111565 PubMed 41285295 Copy citation Copy BibTeX Progress in Neuro-Psychopharmacology and Biological Psychiatry 2025-11-21 Danica E. Johnson, Shakila Meshkat, Erica Kaczmarek, Jennifer S. Rabin, Ryan M. Brudner, Noah Chisamore OpenAlex Published psilocybin DepressionChronic PainRandomized Controlled Trial Randomized Controlled Trial More
Select for export Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psyche.2025.100006 Copy citation Copy BibTeX Psychedelics 2025-11-19 Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafaelle Lancelotta, Alan K. Davis OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/medsci13040277 PubMed 41283278 Copy citation Copy BibTeX Medical Sciences 2025-11-19 Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-18 Beersheva Mental Health Center ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionBiomarkersMicrodosing Clinical Trial More
Select for export Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-18 Beersheva Mental Health Center ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2025-11-15 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionMicrodosingWellbeing Clinical Trial More
Select for export Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psyche.2025.100004 Copy citation Copy BibTeX Psychedelics 2025-11-14 Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis OpenAlex Published psilocybin DepressionPTSDAddiction Observational Study More
Select for export Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03693-w PubMed 41257994 Copy citation Copy BibTeX Translational Psychiatry 2025-11-12 Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export ‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain No abstract availability was recorded for this entry. Details DOI 10.1038/s41583-025-00999-y PubMed 41219396 Copy citation Copy BibTeX Nature reviews. Neuroscience 2025-11-10 Sian Lewis OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other More
Select for export Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression” No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2025.120637 PubMed 41224017 Copy citation Copy BibTeX Journal of Affective Disorders 2025-11-10 Max Wolff, Samuli Kangaslampi OpenAlex Published psilocybin DepressionChronic PainPharmacology Other More
Select for export Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.5c07092.s001 Copy citation Copy BibTeX Figshare 2025-11-09 Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723) OpenAlex Published psilocybinpsilocin DepressionToxicity Clinical Trial More
Select for export Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.5c07092 PubMed 41322617 Copy citation Copy BibTeX ACS Omega 2025-11-09 Luisina Castelli Rodríguez, Guillermo Morera, Sandra Lupo, Danilo Davyt, Ignacio Carrera, Gonzalo Hernández Dossi OpenAlex Published psilocybinpsilocin DepressionToxicity Clinical Trial More
Select for export Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.11.06.687023 Copy citation Copy BibTeX bioRxiv 2025-11-06 Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2025.09.011 PubMed 41205366 Copy citation Copy BibTeX Unknown journal 2025-11-06 Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
